Antibiotic administration to patients with preterm premature rupture of membranes does not eradicate intra-amniotic infection

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 2, 2007, Pages 167-173

  Gomez, Ricardo ^a   Romero, Roberto ^b,c,g   Nien, Jyh Kae ^b,c   Medina, Luis ^a   Carstens, Mario ^a   Kim, Yeon Mee ^b,c,d   Espinoza, Jimmy ^b,c,d   Chaiworapongsa, Tinnakorn ^b,e   Gonzalez, Rogelio ^a   Iams, Jay D ^f   Rojas, Iván ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c Wayne State University School of Medicine ^*

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Amniocentesis; Antibiotic therapy; Chorioamnionitis; Rupture of membranes

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CLINDAMYCIN; ERYTHROMYCIN; STEROID; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AEROBIC BACTERIUM; AMNIOCENTESIS; AMNION; AMNION FLUID; AMNION FLUID ANALYSIS; AMNIONITIS; ANAEROBIC BACTERIUM; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; FETUS; GESTATIONAL AGE; GRAM STAINING; HOSPITALIZATION; HUMAN; INFLAMMATION; LEUKOCYTE; LEUKOCYTE CULTURE; MICROORGANISM; MYCOPLASMA; OUTCOME ASSESSMENT; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; CHORIOAMNIONITIS; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MYCOPLASMA HOMINIS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; UREAPLASMA UREALYTICUM;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHORIOAMNIONITIS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; MYCOPLASMA HOMINIS; MYCOPLASMA INFECTIONS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; UREAPLASMA INFECTIONS; UREAPLASMA UREALYTICUM;

EID: 34248532638     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050601135485     Document Type: Article

References (43)

1. Parry S, Strauss JF, III. Premature rupture of the fetal membranes. N Engl J Med 1998;38:663-670.
2. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:78-193.
3. Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515-1528.
4. Merenstein GB, Weisman LE. Premature rupture of the membranes: Neonatal consequences. Semin Perinatol 1996;20:375-380.
5. Moutquin JM. Classification and heterogeneity of preterm birth. BJOG 2003;110(Suppl 20):30-33.
6. Romero R, Quintero R, Oyarzun E, Wu YK, Sabo V, Mazor M, Hobbins JC Intraamniotic infection and the onset of labor in preterm premature rupture of the membranes. Am J Obstet Gynecol 1988;159:661-666.
7. Romero R, Ghidini A, Mazor M, Behnke E. Microbial invasion of the amniotic cavity in premature rupture of membranes. Clin Obstet Gynecol 1991;34:769-778.
8. Arias F, Tomich P. Etiology and outcome of low birth weight and preterm infants. Obstet Gynecol 1982;60:277-281.
9. Montan S, Holmquist P, Ingesson K, Ingemarsson I. Fetal and infant outcome of pregnancies with very early rupture of membranes. Acta Obstet Gynecol Scand 1991;70:119-124.
10. Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997;11:135-176.
11. Shumway JB, Al Malt A, Amon E, Cohlan B, Amini S, Abboud M, Winn HN. Impact of oligohydramnios on maternal and perinatal outcomes of spontaneous premature rupture of the membranes at 18-28 weeks. J Matern Fetal Med 1999;8:20-23.
12. Meirowitz NB, Ananth CV, Smulian JC, Vintzileos AM. Effect of labor on infant morbidity and mortality with preterm premature rupture of membranes: United States population-based study. Obstet Gynecol 2001;97:494-498.
13. Tanir HM, Sener T, Tekin N, Aksit A, Ardic N. Preterm premature rupture of membranes and neonatal outcome prior to 34 weeks of gestation. Int J Gynaecol Obstet 2003;82:167-172.
14. Dinsmoor MJ, Bachman R, Haney EI, Goldstein M, Mackendrick W. Outcomes after expectant management of extremely preterm premature rupture of the membranes. Am J Obstet Gynecol 2004;190:183-187.
15. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm premature rupture of membranes. Cochrane Database Syst Rev 2001;CD001058.
16. Kenyon SL, Taylor DJ, Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: The ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001;357:979-988.
17. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, Rabello YA, Meis PJ, Moawad AH, Iams JD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA 1997;278:989-995.
18. Lewis DF, Brody K, Edwards MS, Brouillette RM, Burlison S, London SN. Preterm premature ruptured membranes: A randomized trial of steroids after treatment with antibiotics. Obstet Gynecol 1996;88:801-805.
19. Ananth CV, Guise JM, Thorp JM Jr. Utility of antibiotic therapy in preterm premature rupture of membranes: A metaanalysis. Obstet Gynecol Surv 1996;51:324-328.
20. Lewis DF, Fontenot MT, Brooks GG, Wise R, Perkins MB, Heymann AR. Latency period after preterm premature rupture of membranes: A comparison of ampicillin with and without sulbactam. Obstet Gynecol 1995;86:392-395.
21. Christmas JT, Cox SM, Andrews W, Dax J, Leveno KJ, Gilstrap LC. Expectant management of preterm ruptured membranes: Effects of antimicrobial therapy. Obstet Gynecol 1992;80:759-762.
22. Reece EA, Chervenak FA, Moya FR, Hobbins JC. Amniotic fluid arborization: Effect of blood, meconium, and pH alterations. Obstet Gynecol 1984;64:248-250.
23. McDuffie RS Jr, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol 1993;82:487-489.
24. Gibbs RS, Blanco JD, St Clair PJ, Castaneda YS. Quantitative bacteriology of amniotic fluid from women with clinical intraamniotic infection at term. J Infect Dis 1982;145:1-8.
25. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, Ghezzi F, Berry SM, Qureshi F, Jacques SM, et al. Funisitis and chorionic vasculitis: The histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18-25.
26. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, Kim KS. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998;179:1254-1260.
27. Yoon BH, Chang JW, Romero R. Isolation of Ureaplasma urealyticum from the amniotic cavity and adverse outcome in preterm labor. Obstet Gynecol 1998;92:77-82.
28. Yoon BH, Romero R, Kim M, Kim EC, Kim T, Park JS, Jun JK. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000;183:1130-1137.
29. Yoon BH, Romero R, Lim JH, Shim SS, Hong JS, Shim JY, Jun JK. The clinical significance of detecting Ureaplasma urealyticum by the polymerase chain reaction in the amniotic fluid of patients with preterm labor. Am J Obstet Gynecol 2003;189:919-924.
30. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2003;CD001058.
31. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998;179:186-193.
32. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194-202.
33. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999;181:773-779.
34. Yoon BH, Romero R, Park JS, Kim CJ, Kim SH, Choi JH, Han TR. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675-681.
35. Bendon RW, Faye-Petersen O, Pavlova Z, Qureshi F, Mercer B, Miodovnik M, Das AF, Meis PJ, Moawad AH, Iams JD, et al. Fetal membrane histology in preterm premature rupture of membranes: Comparison to controls, and between antibiotic and placebo treatment. The National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network, Bethesda, MD, USA. Pediatr Dev Pathol 1999;2:552-558.
36. Gibbs RS, Davies JK, McDuffie RS Jr, Leslie KK, Sherman MP, Centretto CA, Wolf DM. Chronic intrauterine infection and inflammation in the preterm rabbit, despite antibiotic therapy. Am J Obstet Gynecol 2002;186:234-239.
37. Romero R, Scioscia AL, Edberg SC, Hobbins JC. Use of parenteral antibiotic therapy to eradicate bacterial colonization of amniotic fluid in premature rupture of membranes. Obstet Gynecol 1986;67:15S-17S.
38. Romero R, Hagay Z, Nores J, Sepulveda W, Mazor M. Eradication of Ureaplasma urealyticum from the amniotic fluid with transplacental antibiotic treatment. Am J Obstet Gynecol 1992;166:618-620.
39. Mazor M, Chaim W, Meirovitz M, Yohay D, Leiberman JR, Glezerman M. Eradication of viridans streptococci from the amniotic cavity by parenteral antibiotic administration. A case report. J Reprod Med 1995;40:820-822.
40. Fidel P, Ghezzi F, Romero R, Chaiworapongsa T, Espinoza J, Cutright J, Wolf N, Gomez R. The effect of antibiotic therapy on intrauterine infection-induced preterm parturition in rabbits. J Matern Fetal Neonatal Med 2003;14:57-64.
41. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000;107:770-775.
42. Witt A, Sommer EM, Cichna M, Postlbauer K, Widhalm A, Gregor H, Reisenberger K. Placental passage of clarithromycin surpasses other macrolide antibiotics. Am J Obstet Gynecol 2003;188:816-819.
43. Cassell G. Isolation of microorganisms from the chorioamnion is twice that from amniotic fluid at cesarean delivery in women with intact membranes. Am J Obstet Gynecol 1993;168:424 (A462).